Literature DB >> 8821945

Molecular characterization of hybrid Tbp2 proteins from Neisseria meningitidis.

M Legrain1, A Findeli, D Villeval, M J Quentin-Millet, E Jacobs.   

Abstract

Transferrin-binding protein 2 (Tbp2) from Neisseria is an outer membrane-associated extracellular lipoprotein that is involved in iron capture within the infected host. The analysis of tbp2 clones isolated from various bacterial strains revealed extensive divergences throughout the open reading frame (ORF), with predicted amino acid (aa) sequences displaying 47% to 83% identity. Such a variability is likely to have resulted from the selective pressure exerted by the host immune system, but raises questions regarding the existing constraints for conservation of protein function. Indeed, the neisserial Tbp2s include a large structured domain, extending throughout the N-terminal half of the protein (approximately 270-290 aa), which is extremely stable and whose conformational integrity is required for efficient binding to human transferrin (hTf). In this work, a functional study of Tbp2s encoded by hybrid genes constructed by reassorting highly divergent tbp2 sequences in the region of the ORF encoding this structured domain was performed. The data demonstrate that the determinant intramolecular interactions allowing formation of a stable Tbp2 structure able to interact efficiently with hTf or/and that the Tbp2 residues involved in the interaction with hTf are not well conserved. However, a number of rearrangements appeared to generate genes encoding proteins which have retained structural stability and hTf-binding capacity. This suggested that despite the extreme aa sequence divergence and the conformational constraints, horizontal genetic exchanges, which are known to occur in neisserial populations, may have contributed significantly to the generation of sequence variation within tbp2 ORFs. The analysis of two tbp2 clones characterized in this work supports this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8821945     DOI: 10.1046/j.1365-2958.1996.364891.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  6 in total

1.  Neisseria meningitidis expressing transferrin binding proteins of Actinobacillus pleuropneumoniae can utilize porcine transferrin for growth.

Authors:  D J Litt; H M Palmer; S P Borriello
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Heterogeneity of tbpB, the transferrin-binding protein B gene, among serogroup B Neisseria meningitidis strains of the ET-5 complex.

Authors:  B Rokbi; M Mignon; D A Caugant; M J Quentin-Millet
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

3.  Identification of transferrin-binding domains in TbpB expressed by Neisseria gonorrhoeae.

Authors:  Amanda J DeRocco; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2007-04-16       Impact factor: 3.441

4.  Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine.

Authors:  B Rokbi; G Renauld-Mongenie; M Mignon; B Danve; D Poncet; C Chabanel; D A Caugant; M J Quentin-Millet
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

5.  Identification of human transferrin-binding sites within meningococcal transferrin-binding protein B.

Authors:  G Renauld-Mongénie; D Poncet; L von Olleschik-Elbheim; T Cournez; M Mignon; M A Schmidt; M J Quentin-Millet
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

6.  Transferrin-binding protein B of Neisseria meningitidis: sequence-based identification of the transferrin-Binding site confirmed by site-directed mutagenesis.

Authors:  Geneviève Renauld-Mongénie; Laurence Lins; Tino Krell; Laure Laffly; Michèle Mignon; Monique Dupuy; Rose-May Delrue; Françoise Guinet-Morlot; Robert Brasseur; Ling Lissolo
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.